The National Health Surveillance Agency of Brazil (Anvisa) announced on Saturday the suspension of the use and distribution of 12.1 million doses of the coronavac anticovid vaccine.
READ ALSO:
According to the Anvisa statement, the measure was taken after the Butantan Institute, responsible for the import and local manufacture of the vaccine, indicated that the batch came from a plant in China not approved by the Brazilian control body.
VACINA
Anvisa determines a precautionary interdiction of coronavac batches, bottled by a factory that has not been inspected and has no authorization from the agency.
Total servings: 12 MILLION
Understand: https://t.co/sctVoeBq4d pic.twitter.com/iGeTRFVBXz
— Coronavirus count – Brazil (24-hour news) (@corona count1)
September 4, 2021
–
–
In a statement, the Butantan Institute reported that the precautionary measure “should not cause scaremongering,” and stressed that it was the Institute itself that reported the matter to Anvisa, “in a commitment to transparency and extreme caution.”
The Brazilian Agency affirmed that the determination to suspend the use of these batches in the country is not punitive, but rather they are sanitary measures to avoid exposure to the consumption and use of irregular or suspicious products.
I spoke with the president of Anvisa, Antonio Barra Torres, about the ban on the use of doses of CoronaVac. According to him, the vaccine is safe and there is no reason to panic. Decision was “cautionary” by the agency. https://t.co/YRydktuyrS
— Paula Ferreira (@_paulaferreira_)
September 4, 2021
–
–
The Coronavac vaccine, from the Chinese laboratory Sinovac, produced in China and in Brazil, through the Butantan Institute, was the first that began to be applied in the South American country in the vaccination campaign against the coronavirus that began on January 17.
–
/i/2004561628.png?resize=150%2C150&ssl=1)